Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: 5.29%
• Average Volume (3M): 116.53K
• Price to Earnings (P/E): 7.3
• Beta (1Y): 0.33
• Revenue Growth: 30.77%
• EPS Growth: -128.09%
• Country: HK
• Employees: 402
• Sector: General
• Sector Strength: N/A
• Industry: Chemicals - Specialty
• EPS (TTM): -0.02
• Shares Outstanding: 955,640,000
• 10 Day Avg. Volume: 118,400
• 30 Day Avg. Volume: 116,533
• PEG Ratio: 0.06
• Price to Book (P/B): 1.28
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 3.68
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 53 Neutral
• Price Target: HK$0.50 ▲(25.00%Upside)

The most significant factor affecting the overall score is the company's financial performance, notably the challenges with profitability and inconsistent growth. Technical analysis provides a moderately positive outlook, while valuation remains a concern due to a negative P/E ratio. The high dividend yield provides a slight positive aspect.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Business Overview & Revenue Model

Company Description

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) is a chemical manufacturing company that operates within the industrial sector. The company specializes in the production and distribution of hydrogenated chemicals, which are used in various applications across multiple industries including pharmaceuticals, agriculture, and manufacturing.

How the Company Makes Money

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. generates revenue primarily through the sale of its hydrogenated chemical products. These products are supplied to a diverse range of industries that require high-quality chemical inputs for their manufacturing processes. The company likely engages in strategic partnerships and long-term contracts with key clients to ensure steady demand and revenue. Additionally, the company may innovate in its product offerings to cater to evolving industry needs, thus maintaining competitive advantage and profitability. However, specific details on partnerships or additional revenue streams are not available.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Financial Statement Overview

Summary

The company struggles with profitability and consistent growth. Despite a revenue increase in 2024, profitability margins have worsened, leading to net losses. The balance sheet is moderately stable, but increasing leverage is a concern. Cash flow management shows some improvements, though inconsistencies persist.

Income Statement

The company has experienced significant volatility in revenue and profitability. The gross profit margin has declined from 12.4% in 2021 to 2.3% in 2024, indicating pressure on cost management. The net profit margin has deteriorated from 4.1% to negative, reflecting net losses in 2024. Revenue growth has been inconsistent, with a decrease of 10.4% from 2022 to 2023, followed by a 33.1% increase in 2024, but this did not translate to profitability. EBIT and EBITDA margins have also fallen, indicating operational inefficiencies.

Balance Sheet

The balance sheet shows moderate financial stability with a debt-to-equity ratio of 0.34 in 2024, up from 0.22 in 2020, indicating increased leverage. The return on equity has turned negative in 2024, reflecting net losses. However, the equity ratio remains strong at 58.8% in 2024, suggesting a solid asset base supported by equity.

Cash Flow

Cash flow performance has been mixed. Free cash flow turned positive in 2024, but overall growth has been inconsistent. The operating cash flow to net income ratio shows cash generation issues with net income losses. The free cash flow to net income ratio improved in 2024, indicating better cash management despite net losses.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	3.10B	2.33B	2.30B	1.46B	1.02B
Gross Profit	71.64M	148.80M	285.51M	142.80M	91.41M
EBITDA	77.03M	163.47M	266.82M	176.34M	113.14M
Net Income	-16.04M	54.92M	121.38M	59.14M	24.48M
Balance Sheet
Total Assets	1.68B	1.66B	1.06B	971.94M	969.90M
Cash, Cash Equivalents and Short-Term Investments	352.62M	300.71M	106.16M	73.03M	78.34M
Total Debt	338.27M	262.97M	219.16M	96.89M	125.83M
Total Liabilities	584.85M	535.95M	334.98M	400.14M	447.76M
Stockholders Equity	985.37M	1.02B	573.79M	457.93M	400.56M
Cash Flow
Free Cash Flow	13.82M	-43.95M	199.74M	44.27M	-21.69M
Operating Cash Flow	96.86M	104.46M	318.82M	94.88M	50.62M
Investing Cash Flow	-268.86M	-71.06M	-150.12M	-59.21M	-72.31M
Financing Cash Flow	2.49M	204.95M	-133.45M	-40.95M	20.11M

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.40
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2502, the sentiment is Positive. The current price of 0.4 is above the 20-day moving average (MA) of 0.39, above the 50-day MA of 0.37, and below the 200-day MA of 0.45, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 69.93 is Neutral, neither overbought nor oversold. The STOCH value of 82.54 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2502.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
0408	74 Outperform	HK$900.34M	9.33	2.51%	13.75%	-1.70%	12.53%
2116	68 Neutral	HK$223.20M	14.72	6.12%	2.15%	-4.13%	-35.11%
Sector *	57 Neutral	HK$22.27B	11.05	-15.60%	15.93%	10.12%	-85.27%
0301	56 Neutral	HK$635.12M	―	-8.95%	―	-3.09%	-480.17%
1986	54 Neutral	HK$840.59M	55.38	-1.16%	6.28%	2.49%	-171.78%
2502	53 Neutral		7.33	-1.60%	5.29%	30.77%	-128.09%

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Corporate Events

Henan Jinyuan Approves AGM Resolutions, No Final Dividend for 2024

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced the successful approval of all resolutions at its annual general meeting held on May 21, 2025. The resolutions included the approval of the company’s financial reports, profit distribution plan, and the appointment of Deloitte Touche Tohmatsu as auditors. Notably, the company decided not to distribute a final dividend for the year ended December 31, 2024, which may impact shareholder returns.

Henan Jinyuan Hydrogenated Chemicals Schedules 2024 AGM with Key Resolutions

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has announced its 2024 Annual General Meeting (AGM) scheduled for May 21, 2025, in Hong Kong. The meeting will address several key resolutions, including the approval of the company’s financial reports, the decision not to distribute a final dividend for 2024, and the appointment of Deloitte Touche Tohmatsu as auditors. Shareholders are encouraged to use proxy forms for voting, highlighting the company’s efforts to facilitate shareholder participation without physical attendance.

Henan Jinyuan Announces Potential Change in Controlling Shareholder

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced a potential change in the shareholding of its controlling shareholder, Jinma Energy. Jinma Coking (BVI) Limited has entered into an agreement to sell its shares in Jinma Energy, which could impact the company’s control structure. The completion of this sale is contingent upon specific conditions, including the disposal of certain shares in the secondary market. Trading in the company’s shares was temporarily halted but is set to resume, and stakeholders are advised to exercise caution.